dylight 649 conjugated tomato lectin Search Results


lycopersicon esculentum tomato lectin conjugated to dylight 649  (Eurobio)
86
Eurobio lycopersicon esculentum tomato lectin conjugated to dylight 649
Functionality and maturation of blood vessels (A) Fluorescence microscopy of TA muscle after DyLight 649-isolectin intravenous injections and tissue clearing of WT and scramble- and mLVRF-treated mice. Scale bars, 100 μm. (B) Fluorescence microscopy after tissue clearing and αSMA staining of EDL muscle of WT and scramble- and mLVRF-treated mice. Scale bars, 500 μm. (C) αSMA (red) and CD31 (green) immunostaining on transverse sections of triceps muscles from WT and scramble-, mLVRF-, ASO-, and mLVRF+ASO-treated mice. Scale bar, 100 μm. (D) Quantification of the number of αSMA+/CD31+ blood vessels per mm 2 from the αSMA and CD31 cross-section stainings (∗ p < 0.05, ∗∗ p < 0.01; analyzed by one-way ANOVA). Results are expressed as the mean ± SEM ( n = 4–5 per group).
Lycopersicon Esculentum Tomato Lectin Conjugated To Dylight 649, supplied by Eurobio, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lycopersicon esculentum tomato lectin conjugated to dylight 649/product/Eurobio
Average 86 stars, based on 1 article reviews
lycopersicon esculentum tomato lectin conjugated to dylight 649 - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

Image Search Results


Functionality and maturation of blood vessels (A) Fluorescence microscopy of TA muscle after DyLight 649-isolectin intravenous injections and tissue clearing of WT and scramble- and mLVRF-treated mice. Scale bars, 100 μm. (B) Fluorescence microscopy after tissue clearing and αSMA staining of EDL muscle of WT and scramble- and mLVRF-treated mice. Scale bars, 500 μm. (C) αSMA (red) and CD31 (green) immunostaining on transverse sections of triceps muscles from WT and scramble-, mLVRF-, ASO-, and mLVRF+ASO-treated mice. Scale bar, 100 μm. (D) Quantification of the number of αSMA+/CD31+ blood vessels per mm 2 from the αSMA and CD31 cross-section stainings (∗ p < 0.05, ∗∗ p < 0.01; analyzed by one-way ANOVA). Results are expressed as the mean ± SEM ( n = 4–5 per group).

Journal: Molecular Therapy. Nucleic Acids

Article Title: Improving angiogenesis ameliorates the efficacy of ASO-based exon skipping for the treatment of Duchenne muscular dystrophy

doi: 10.1016/j.omtn.2026.102834

Figure Lengend Snippet: Functionality and maturation of blood vessels (A) Fluorescence microscopy of TA muscle after DyLight 649-isolectin intravenous injections and tissue clearing of WT and scramble- and mLVRF-treated mice. Scale bars, 100 μm. (B) Fluorescence microscopy after tissue clearing and αSMA staining of EDL muscle of WT and scramble- and mLVRF-treated mice. Scale bars, 500 μm. (C) αSMA (red) and CD31 (green) immunostaining on transverse sections of triceps muscles from WT and scramble-, mLVRF-, ASO-, and mLVRF+ASO-treated mice. Scale bar, 100 μm. (D) Quantification of the number of αSMA+/CD31+ blood vessels per mm 2 from the αSMA and CD31 cross-section stainings (∗ p < 0.05, ∗∗ p < 0.01; analyzed by one-way ANOVA). Results are expressed as the mean ± SEM ( n = 4–5 per group).

Article Snippet: To visualize the vasculature, mice were intravenously injected with 200 μL of Lycopersicon esculentum (tomato) lectin conjugated to DyLight 649 (Eurobio, Les Ulis, France, DL-1178) 30 min prior to sacrifice.

Techniques: Fluorescence, Microscopy, Staining, Immunostaining, Muscles